Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,592,655 | 2,793,370 | 3,171,800 | 3,078,884 | 3,420,061 |
| Marketable Securities | N/A | N/A | N/A | 106,989 | 105,693 |
| Receivables | 529,449 | 435,294 | 358,027 | 309,079 | 299,282 |
| Inventories | 443,260 | 447,345 | 416,122 | 316,929 | 321,333 |
| TOTAL | $3,839,022 | $3,907,750 | $4,203,414 | $4,053,542 | $4,401,419 |
| Non-Current Assets | |||||
| PPE Net | 1,516,491 | 1,417,992 | 1,324,154 | 1,178,038 | 1,031,938 |
| Intangibles | 53,715 | 55,171 | 57,138 | 53,657 | 46,895 |
| Other Non-Current Assets | 302,951 | 286,768 | 220,569 | 239,642 | 248,484 |
| TOTAL | $1,873,157 | $1,759,931 | $1,601,861 | $1,471,337 | $1,327,317 |
| Total Assets | $5,712,179 | $5,667,681 | $5,805,275 | $5,524,879 | $5,728,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 333,022 | 356,575 | 315,111 | 341,857 | 266,975 |
| Accrued Expenses | 646,538 | 569,438 | 693,731 | 505,824 | 454,950 |
| Other current liabilities | 84,615 | 81,986 | 68,004 | 63,652 | 62,516 |
| TOTAL | $1,938,768 | $1,881,689 | $1,810,113 | $1,283,297 | $1,405,109 |
| Non-Current Liabilities | |||||
| Long Term Debt | 185,271 | 199,027 | 197,618 | 202,491 | 207,426 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 159,034 |
| Other Non-Current Liabilities | 205,943 | 210,167 | 243,723 | 259,199 | 277,714 |
| TOTAL | $407,156 | $425,631 | $457,835 | $478,348 | $525,068 |
| Total Liabilities | $2,345,924 | $2,307,320 | $2,267,948 | $1,761,645 | $1,930,177 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,118 | 104,579 | 104,578 | 104,577 | 105,867 |
| Common Shares | 137 | 136 | 135 | 135 | 137 |
| Retained earnings | -8,333,605 | -8,213,200 | -7,962,050 | -7,594,497 | -7,809,910 |
| Other shareholders' equity | -140,477 | -131,645 | -99,448 | -144,934 | -143,688 |
| TOTAL | $3,366,255 | $3,360,361 | $3,537,327 | $3,763,234 | $3,798,559 |
| Total Liabilities And Equity | $5,712,179 | $5,667,681 | $5,805,275 | $5,524,879 | $5,728,736 |